Internal Server Error

About Kaiser Permanente Ventures

Kaiser Permanente Ventures is a venture capital firm founded in 1997. It is primarily based out of Oakland, United States. As of May 2026, Kaiser Permanente Ventures is an active investor, having invested in 83 companies, with 2 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series E round of Garner Health Overall, Kaiser Permanente Ventures portfolio has seen 7 unicorns, 7 IPOs and 41 acquisitions including key companies like Omada, Abridge Inc and iRhythm Tech. A lot of funds co-invest with Kaiser Permanente Ventures, with names like Investor Growth Capital sharing a substantial percentage of its portfolio. Kaiser Permanente Ventures has team of 5 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Series B, Series A & 4 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Kaiser Permanente Ventures' List of Top Investments

Kaiser Permanente Ventures has a portfolio of 83 companies, including 7 unicorns. Their most notable investments are in Chrono Therapeutics and Transcend Medical.Their portfolio spans across United States, China, United Kingdom and 1 more locations. They have invested in Life Sciences, Enterprise Applications, HealthTech and 14 other sectors, across stages such as Series B, Series A  and 4 more. Here is the list of top investments by Kaiser Permanente Ventures:
Provider of virtual care programs to manage chronic diseases. The company provides access to personal health coaches and specialists for virtual programs to deliver personalized interventions for prediabetes, diabetes, hypertension, and musculoskeletal issues.

Key facts about Omada

Provider of AI-based health record platform. It offers a platform offering solutions for individuals to record health details. The users can communicate with the doctors on the care needs and symptoms. The recorded conversation can be presented to the doctor during the appointment. The app highlights the important points during the conversation. The previous record can be maintained in the app for future reference.

Key facts about Abridge Inc

Provider of cloud-based cardiac rhythm monitoring devices. It provides Zio ambulatory ECG monitor a wearable patch designed to gather beat-to-beat heart data for the diagnosis of cardiac arrhythmias. The device stores data in the patch and is emailed to the iRhythm cloud at the end of the monitoring period. myZio iPhone app is an add-on for the Zio Patch for physicians to make a diagnosis.

Key facts about iRhythm Tech

Cloud based platform offering data analytics solutions for healthcare organizations. It provides analytical products, services, and applications that include solutions such as population health management, patient injury prevention, operational efficiency, performance monitoring, and financial management. The company also designs, develops, and delivers multiple data warehouse software and processes to help hospitals manage operational, financial, clinical, and research data.

Key facts about Health Catalyst

  • Founded Year: 2008
  • Location: Salt Lake City (United States)
  • Annual Revenue: $100M - $500M as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $392M
  • Employee Count: 1,425 as on Jul 31, 2026
  • Investors: HTIF, Allumia Ventures and 26 Others
  • Latest Funding Round: Post IPO, Sep 08, 2020, $*****
  • Highlight: Public
Provider of mental health support services via application and human care. The company delivers personalized support through meditation, mindfulness, coaching, and therapy. It offers resources for stress management, sleep improvement, and mental well-being. The company also provides services to businesses, health plans, and organizations.

Key facts about Headspace

Kaiser Permanente Ventures' Investments by Stage

Kaiser Permanente Ventures has made 26 investments in Series B stage with an average round size of $32.5M, 14 investments in Series A stage with an average round size of $15.3M and 13 investments in Series C stage with an average round size of $92.2M.
Here are Kaiser Permanente Ventures' investments by stage:
Stage of entry
No. of Investments
Series B
26
Series A
14
Series C
13
Series D
7
Series E
4
Others
2
Breakdown of Kaiser Permanente Ventures' investments by stage of entrySeries B (26)Series A (14)
Note: We have considered here, only first round of investments

Kaiser Permanente Ventures' Investments by Sector

Kaiser Permanente Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, HealthTech, High Tech and Vertical SaaS. Notably, it has invested in 68 Tech companies, 64 Enterprise (B2B) companies, 45 Software companies and at least 20 companies focusing on Saas.
Here are Kaiser Permanente Ventures' investments by sector:
Sector
No. of Investments
Enterprise Applications
30
Life Sciences
29
HealthTech
28
High Tech
15
Vertical SaaS
9
Others
36
Breakdown of Kaiser Permanente Ventures' investments by sectorsEnterprise Applic... (30)Life Sciences (29)
Note: We have considered here, only first round of investments

Kaiser Permanente Ventures' Investments by Geography

Kaiser Permanente Ventures has made most investments in United States (63), followed by China where it has made 2 investments.
Here are Kaiser Permanente Ventures' investments by geography:
Country
No. of Investments
United States
63
China
2
Canada
1
United Kingdom
1
Breakdown of Kaiser Permanente Ventures' investments by countriesUnited States (63)China (2)
Note: We have considered here, only first round of investments

Kaiser Permanente Ventures' recent investments

Kaiser Permanente Ventures has made 2 investments in 2026 so far - Garner Health and Garner Health.
Here are the most recent investments by Kaiser Permanente Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
May 28, 2026
United States
Series E
5824
Feb 10, 2026
United States
Series D
1177
Sep 30, 2025
United States
Series A
1467
Jun 24, 2025
United States
Series C
5096
May 08, 2025
United States
Series A
3329
  [+4]

Unicorns in Kaiser Permanente Ventures' Portfolio

Kaiser Permanente Ventures has 7 unicorns in its portfolio - Garner Health, Abridge Inc, IntelyCare and others. The most recent unicorn in their portfolio is Garner Health. It became a unicorn in 2026.
Here is a list of unicorns in Kaiser Permanente Ventures' portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
52
Provider of data analytics platform for healthcare cost and quality
2019
New York
Series E
lptrroj
78
Provider of AI-based health record platform
2018
Pittsburgh
Series E
lqsiwju
51
Online contract workforce recruitment platform for nurses
2016
Quincy
Series C
ouf{ngk
66
Provider of a deep learning platform for detecting circulating cancer-related markers
2014
-
Series E
lkqcgca
72
Provider of mental health support services via application and human care
2010
Santa Monica
Series C
eskoxez

IPOs and Publicly Listed companies in Kaiser Permanente Ventures' Portfolio

7 of Kaiser Permanente Ventures' portfolio companies have become public. Omada got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2025 at marketcap of $1.06B and Pulmonx got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $645M.
Here are Kaiser Permanente Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 06, 2025
Jun 19, 2014
Series B
3252
Oct 01, 2020
-
-
6813
Jul 25, 2019
Feb 08, 2013
Series B
7950
Nov 14, 2018
Aug 14, 2008
Series E
7419
Oct 20, 2016
Jan 25, 2012
Series C
1448

Acquired companies in Kaiser Permanente Ventures' Portfolio

41 companies from Kaiser Permanente Ventures' portfolio have been acquired. The most recent acquisition was Validic in Jun 2026 by ChartSpan for $*****.
Here are Kaiser Permanente Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jun 22, 2026
Apr 28, 2015
Series B
3864
Dec 09, 2025
-
-
9961
May 12, 2025
Nov 12, 2020
Series B
5540
Jan 09, 2025
Jul 19, 2017
Series A
4409
Oct 14, 2024
Apr 06, 2023
Series F
5512

Team profile of Kaiser Permanente Ventures

Kaiser Permanente Ventures has a team of 5 members including 2 Partners and 1 Principal located in United States and Philippines. Kaiser Permanente Ventures' team does not sit on the board of any company as of now.
Here is a list of all team members in Kaiser Permanente Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Washington
-
-
Partner
Philippines
-
-
Principal
San Francisco
-
-

Co-investors of Kaiser Permanente Ventures

Over the past 24 years, 598 investors have co-invested in Kaiser Permanente Ventures's portfolio companies. This includes funds and angels.

Recent News related to Kaiser Permanente Ventures

View all news related to Kaiser Permanente Ventures

FAQs about Kaiser Permanente Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford